Insmed Incorporated PT Raised to $31.00 at UBS AG (INSM)
Insmed Incorporated logoAnalysts at UBS AG increased their price objective on shares of Insmed Incorporated (NASDAQ:INSM) from $17.50 to $31.00 in a research report issued to clients and investors on Monday, Analyst Ratings News reports. The firm currently has a “buy” rating on the stock. UBS AG’s price objective would indicate a potential upside of 82.03% from the company’s current price.
Insmed Incorporated (NASDAQ:INSM) traded up 3.29% during mid-day trading on Monday, hitting $17.59. The stock had a trading volume of 229,923 shares. Insmed Incorporated has a 1-year low of $5.56 and a 1-year high of $17.60. The stock’s 50-day moving average is $16.08 and its 200-day moving average is $13.92. The company’s market cap is $687.9 million.
Insmed Incorporated (NASDAQ:INSM) last issued its quarterly earnings data on Tuesday, November 5th. The company reported ($0.46) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.41) by $0.05. Analysts expect that Insmed Incorporated will post $-1.65 EPS for the current fiscal year.